SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension. - Wikidata - awgldk - TriplyDB

SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension.

SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension.

http://www.wikidata.org/entity/Q33994653

about

Pharmacotherapy for pulmonary hypertension Hydrocortisone normalizes phosphodiesterase-5 activity in pulmonary artery smooth muscle cells from lambs with persistent pulmonary hypertension of the newborn.Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn.The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension Therapeutic approaches using nitric oxide in infants and children.Right ventricular cyclic nucleotide signaling is decreased in hyperoxia-induced pulmonary hypertension in neonatal mice.Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn.Hydrocortisone normalizes oxygenation and cGMP regulation in lambs with persistent pulmonary hypertension of the newborn Cross talk between NADPH oxidase and autophagy in pulmonary artery endothelial cells with intrauterine persistent pulmonary hypertension Brief hyperoxia increases mitochondrial oxidation and increases phosphodiesterase 5 activity in fetal pulmonary artery smooth muscle cells.Sildenafil attenuates vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity.Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.Reactive oxygen species and antioxidants in pulmonary hypertension.Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension.Disrupted pulmonary artery cyclic guanosine monophosphate signaling in mice with hyperoxia-induced pulmonary hypertension.Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension.Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.Role of reactive oxygen species in neonatal pulmonary vascular disease.Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension.Cytoskeletal remodeling and regulation of cell fate in the hypertensive neonatal pulmonary artery in response to stress.Cyclic stretch induces inducible nitric oxide synthase and soluble guanylate cyclase in pulmonary artery smooth muscle cells Fasudil and SOD packaged in peptide-studded-liposomes: Properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs.Dose-dependent effects of glucocorticoids on pulmonary vascular development in a murine model of hyperoxic lung injury.Isolation of pulmonary artery smooth muscle cells from neonatal mice.Diagnosis and treatment of pulmonary hypertension in infancy.Beyond pulmonary hypertension: sildenafil for chronic lung disease of prematurity.Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.Redox Signaling and Persistent Pulmonary Hypertension of the Newborn.Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency.Domain Mapping of Heat Shock Protein 70 Reveals That Glutamic Acid 446 and Arginine 447 Are Critical for Regulating Superoxide Dismutase 2 Function.Antenatal hypoxia and pulmonary vascular function and remodeling.Redistribution of Extracellular Superoxide Dismutase Causes Neonatal Pulmonary Vascular Remodeling and PH but Protects Against Experimental Bronchopulmonary Dysplasia.

P2860

Q27022763-EC065C82-435B-4FF8-8C92-5735B9450B2B Q33805971-47437D5A-9D6A-476C-9AEE-313AC70D3923 Q34348585-DCD338B1-9175-4BDC-8F4F-E344641D136E Q34370825-9E32149E-48FB-42A3-B55C-DA37065975D8 Q34627552-7CB50B17-01A3-4E6C-8B7C-A346BCB4A190 Q35165230-AC3E5DB4-F7E7-448F-891B-9B2A6A9F310F Q35749616-BB9A82A5-DE07-4024-A206-1F29790CAE05 Q35850312-F5FDB715-1809-4E63-886D-C7FA10401549 Q35850324-3D345BA0-BFFF-4CEE-871E-84D8B95DB2AF Q35900814-128E8865-AA95-4FDD-A58B-8B87C87A1457 Q36001831-82840470-5B23-4CB2-B46D-79BB5BC278D8 Q36103389-DFE99164-9C51-4528-98BB-B040E64AB05A Q36730928-E3276D5A-E147-427D-ABFC-854B4D0E97F8 Q36747034-E792F4A8-05D0-42C5-B8EF-3A4DD408724E Q36766005-DB51997D-0C9B-4130-8459-149BEAD938EA Q37596144-F51B7D6A-A9AA-49AC-9AD2-ADC0815B43FC Q37893072-96716F23-1CEE-4DF7-BBF6-3B1F0446B3D3 Q37985076-D7A5CAA7-CEC2-498D-BEC8-DA0CFF605FEA Q38172267-B225E1C3-1939-46A9-AB30-CF1D4C947281 Q38632257-B4997261-4F81-4D8A-AA98-1F8D7DB0E33D Q39240587-603062F8-ECB4-4C26-A80F-838A0DFCB0E0 Q39463724-E1D9B87B-1DDB-4315-80AC-77294AFCCBA8 Q40854694-ABD8B368-3CDD-469F-AE97-4691268F4BAC Q40881072-2A13DB98-61B5-47DE-997F-03397CC20676 Q42000773-EF1B52D2-0EDC-422E-A029-A91F125FB766 Q42508912-0F06BEDF-858E-473E-B505-AFE7AAC18EDE Q44062958-EDC75293-86DB-4377-BB57-47EB2E08BF75 Q44589946-3F7848D9-F16D-4F63-B2F2-16FA312C3DDA Q46280851-C2C8E28A-C420-4353-9EEC-A5E0B22A8593 Q48273119-0C747907-45AB-4D94-B757-4FA1ECFFFD6F Q49814595-2D1DB7E2-EB11-4CBA-BF3E-8878DC06BD34 Q55110701-BA7E0800-AFF1-4001-8EE8-3A56DC27EE61 Q55188252-FB78B741-4788-4A97-9A55-961C51A45FB7

P2860

SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension.

http://www.wikidata.org/entity/Q33994653

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

SOD and inhaled nitric oxide n ...... istent pulmonary hypertension.

@ast

SOD and inhaled nitric oxide n ...... istent pulmonary hypertension.

@en

type

label

SOD and inhaled nitric oxide n ...... istent pulmonary hypertension.

@ast

SOD and inhaled nitric oxide n ...... istent pulmonary hypertension.

@en

prefLabel

SOD and inhaled nitric oxide n ...... istent pulmonary hypertension.

@ast

SOD and inhaled nitric oxide n ...... istent pulmonary hypertension.

@en

P1433

Q33994653-FE07C5BC-6840-4FDD-99D3-E461E64A9E43

P1476

Q33994653-1867CE1F-8338-4FAE-83E5-215054A1096D

P2093

Q33994653-16B92D36-B9D7-4262-8FA0-852EA80B70C0

Q33994653-1D1F3079-7536-4AF2-AD2D-E08108ABAA5A

Q33994653-34A35646-3DA9-4FDF-B81C-BB53ED6F3125

Q33994653-A863BF3D-B6A5-4300-A258-0AE51D107CFC

Q33994653-B537614F-6C12-4DC8-914E-3C1D27FE63F8

Q33994653-CB43EE8A-F14B-4022-81D1-BFBBCDEF50AB

Q33994653-D1054A3F-F52C-4BD6-A175-454668220BFB

P2860

Q33994653-08359431-ED25-4D08-A33E-3A315B98F439

Q33994653-0B86FF93-75EB-4592-AA88-74FFB99DEFC3

Q33994653-1B04084B-CEAD-466B-81EB-F7234F0154DB

Q33994653-1B530105-2931-4451-B4C1-372BC8AE9028

Q33994653-1C21D2AE-E5D9-444A-B7E7-BC9E59E3A83F

Q33994653-2316A4A6-DC7A-4A7B-993F-2708BFC2EFCF

Q33994653-24D5799E-7964-49C7-92A7-42CEA5158A1A

Q33994653-27E04883-C373-48BF-93D8-CE17EAD34325

Q33994653-34652132-2F1D-427F-826F-CACE87E80AEB

Q33994653-364A2049-E07E-42D1-9F1B-53AFC95C5AB1

P304

Q33994653-3634C27F-CD17-439A-AD7B-97FB5C48D059

P31

Q33994653-7767D29C-2D10-4ED3-B79E-FE3BF33E4E3A

P356

Q33994653-9DDD04AC-2AB9-4442-80CC-FBA5421EF0C0

P433

Q33994653-126F7373-A088-4125-B668-40908C5593B0

P478

Q33994653-49A8FE77-899D-4374-A5F3-AFFFC7E34B23

P50

Q33994653-00316E3A-F9DF-4573-862A-0CEDFA8D2DA9

P577

Q33994653-87A1F30B-872A-40BB-A37E-4D7F9453CB46

P698

Q33994653-F4F1A591-63FC-4CE9-8589-AC2B9FD3D036

P932

Q33994653-746CF373-D402-4783-BF23-8F31009D62B3

P356

AJPLUNG.00309.2009

P1433

American Journal of Physiology - Lung Cellular and Molecular Physiology

P1476

SOD and inhaled nitric oxide n ...... istent pulmonary hypertension.

@en

P2093

Beezly S Groh

http://www.w3.org/2001/XMLSchema#string

James A Russell

http://www.w3.org/2001/XMLSchema#string

Jonathan M Davis

http://www.w3.org/2001/XMLSchema#string

Kathryn N Farrow

http://www.w3.org/2001/XMLSchema#string

Lyubov Czech

http://www.w3.org/2001/XMLSchema#string

Robin H Steinhorn

http://www.w3.org/2001/XMLSchema#string

Sylvia F Gugino

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Extracellular superoxide dismutase in biology and medicine

Vascular protection: superoxide dismutase isoforms in the vessel wall

Sildenafil ameliorates effects of inhaled nitric oxide withdrawal

Inducible platelet-derived growth factor D-chain expression by angiotensin II and hydrogen peroxide involves transcriptional regulation by Ets-1 and Sp1

Soluble guanylate cyclase gene expression and localization in rat lung after exposure to hypoxia.

Regulation of human PDE5A2 intronic promoter by cAMP and cGMP: identification of a critical Sp1-binding site.

Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs.

Pulmonary vascular biology during neonatal transition.

P304

L109-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPLUNG.00309.2009

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

299

http://www.w3.org/2001/XMLSchema#string

P50

Satyan Lakshminrusimha

P577

2010-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20400523

http://www.w3.org/2001/XMLSchema#string

P932

2904095

http://www.w3.org/2001/XMLSchema#string